PTJ
IDXX icon

Paul Tudor Jones’s Idexx Laboratories IDXX Stock Holding History

Paul Tudor Jones’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-800
Closed -$511K – 3729
2025
Q3 		$511K Sell
800
-1,200
-60% -$728K ﹤0.01% 2685
2025
Q2 		$1.07M Sell
2,000
-700
-26% -$335K ﹤0.01% 2089
2025
Q1 		$1.13M Sell
2,700
-3,200
-54% -$1.39M ﹤0.01% 1738
2024
Q4 		$2.44M Buy
5,900
+5,100
+638% +$2.24M 0.01% 1121
2024
Q3 		$404K Buy
+800
New +$389K ﹤0.01% 2156
2023
Q2 		– Sell
-2,000
Closed -$1M – 2662
2023
Q1 		$1M Sell
2,000
-1,100
-35% -$526K 0.02% 1203
2022
Q4 		$1.27M Buy
3,100
+500
+19% +$194K 0.03% 941
2022
Q3 		$847K Buy
2,600
+2,000
+333% +$735K 0.02% 1032
2022
Q2 		$210K Buy
600
+100
+20% +$40.8K 0.01% 1789
2022
Q1 		$274K Buy
500
+100
+25% +$52.6K 0.01% 1604
2021
Q4 		$264K Sell
400
-400
-50% -$251K ﹤0.01% 1930
2021
Q3 		$497K Buy
+800
New +$538K 0.01% 1655

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Paul Tudor Jones's IDXX Position: Q2 2026 in Review

Paul Tudor Jones sold out of Idexx Laboratories (IDXX) in Q2 2026, closing a stake of 8,342 shares — an estimated $4.69M sold.

Paul Tudor Jones first reported a position in IDXX in Q2 2013 and held it in 30 quarters. The position peaked at $16M in Q1 2025. 1,293 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Paul Tudor Jones reported no remaining Idexx Laboratories position as of Q2 2026 after selling out during the quarter.
  • Paul Tudor Jones sold 8,342 Idexx Laboratories shares in Q2 2026, an estimated $4.69M.
  • Paul Tudor Jones first reported a position in Idexx Laboratories in Q2 2013 and held it in 30 quarters.
  • Paul Tudor Jones's Idexx Laboratories position peaked at $16M in Q1 2025.
  • 1,293 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.